Cargando…

Ursolic Acid Alleviates Cancer Cachexia and Prevents Muscle Wasting via Activating SIRT1

SIMPLE SUMMARY: Cancer cachexia is a multifactorial condition characterized by body weight loss and skeletal muscle wasting that negatively impacts the quality of life and survival of cancer patients. In this paper, we found that ursolic acid (UA) alleviated cancer cachexia and prevented muscle wast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Weili, Ouyang, Ze, Liao, Zhiqi, Li, Lu, Zhang, Yujie, Gao, Jiali, Ma, Li, Yu, Shiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136986/ https://www.ncbi.nlm.nih.gov/pubmed/37190306 http://dx.doi.org/10.3390/cancers15082378

Ejemplares similares

Pharmacological Inhibition of HMGB1 Prevents Muscle Wasting
por: Li, Lu, et al.
Publicado: (2021)

Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia
por: Chiappalupi, Sara, et al.
Publicado: (2020)

Exploring the Therapeutic Potential of Ethyl 3-Hydroxybutyrate in Alleviating Skeletal Muscle Wasting in Cancer Cachexia
por: Zhou, Yu, et al.
Publicado: (2023)

Cardiac muscle wasting in individuals with cancer cachexia
por: Barkhudaryan, Anush, et al.
Publicado: (2017)

Mathematical Model of Muscle Wasting in Cancer Cachexia
por: Farhang-Sardroodi, Suzan, et al.
Publicado: (2020)

Inflammation and Skeletal Muscle Wasting During Cachexia
por: Webster, Justine M., et al.
Publicado: (2020)

Amelioration of muscle wasting by gintonin in cancer cachexia
por: Wijaya, Yoseph Toni, et al.
Publicado: (2021)

The translation inhibitor pateamine A prevents cachexia-induced muscle wasting in mice
por: Di Marco, Sergio, et al.
Publicado: (2012)

Peptide‐2 from mouse myostatin precursor protein alleviates muscle wasting in cancer‐associated cachexia
por: Ojima, Chiharu, et al.
Publicado: (2020)

2-Deoxy-D-glucose Alleviates Cancer Cachexia-Induced Muscle Wasting by Enhancing Ketone Metabolism and Inhibiting the Cori Cycle
por: Wei, Lulu, et al.
Publicado: (2022)

Preclinical Investigation of Alpinetin in the Treatment of Cancer-Induced Cachexia via Activating PPARγ
por: Zhang, Yujie, et al.
Publicado: (2021)

Nutraceuticals and Exercise against Muscle Wasting during Cancer Cachexia
por: Aquila, Giorgio, et al.
Publicado: (2020)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2019)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2020)

Ursolic acid alleviates airway-vessel remodeling and muscle consumption in cigarette smoke-induced emphysema rats
por: Lin, Li, et al.
Publicado: (2019)

Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response
por: Guo, Dunwei, et al.
Publicado: (2017)

Mitophagy-mediated inflammation and oxidative stress contribute to muscle wasting in cancer cachexia
por: Zhang, Zhige, et al.
Publicado: (2023)

The role of insulin resistance in the development of muscle wasting during cancer cachexia
por: Honors, Mary A., et al.
Publicado: (2011)

Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia
por: Ábrigo, Johanna, et al.
Publicado: (2018)

Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia
por: Rausch, Valentina, et al.
Publicado: (2021)

β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy
por: Kim, Yerin, et al.
Publicado: (2023)

Suppression of muscle wasting by the plant‐derived compound ursolic acid in a model of chronic kidney disease
por: Yu, Rizhen, et al.
Publicado: (2016)

Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling
por: Chen, Xiangzheng, et al.
Publicado: (2016)

CHAC1 inactivation is effective to preserve muscle glutathione but is insufficient to protect against muscle wasting in cachexia
por: Li, Junjie, et al.
Publicado: (2023)

Pharmacological or genetic inhibition of iNOS prevents cachexia‐mediated muscle wasting and its associated metabolism defects
por: Sadek, Jason, et al.
Publicado: (2021)

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training
por: Lenk, Karsten, et al.
Publicado: (2010)

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training
por: Bowen, T Scott, et al.
Publicado: (2015)

Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia
por: Damrauer, Jeffrey S., et al.
Publicado: (2018)

The role of microRNA in cancer cachexia and muscle wasting: A review article
por: Sutandyo, Noorwati
Publicado: (2021)

The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia
por: Cheung, Wai W., et al.
Publicado: (2021)

MicroRNAs in Skeletal Muscle and Hints on Their Potential Role in Muscle Wasting During Cancer Cachexia
por: Marceca, Gioacchino P., et al.
Publicado: (2020)

Creatine modulates cellular energy metabolism and protects against cancer cachexia-associated muscle wasting
por: Wei, Lulu, et al.
Publicado: (2022)

Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release
por: Zhou, Lin, et al.
Publicado: (2021)

STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia
por: Bonetto, Andrea, et al.
Publicado: (2011)

Coix seed oil ameliorates cancer cachexia by counteracting muscle loss and fat lipolysis
por: Liu, Huiquan, et al.
Publicado: (2019)

Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia
por: Hall, Derek T., et al.
Publicado: (2011)

Eicosapentaenoic Acid and Oxypurinol in the Treatment of Muscle Wasting in a Mouse Model of Cancer Cachexia
por: Vaughan, Vanessa C., et al.
Publicado: (2012)

Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia
por: Pedroso, Felipe E., et al.
Publicado: (2012)

Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention
por: Anker, Stefan D., et al.
Publicado: (2014)

Aerobic Exercise Ameliorates Cancer Cachexia-Induced Muscle Wasting through Adiponectin Signaling
por: Morinaga, Makoto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kptvmkpvhpg5n2i3gsfe6v2lns